290 related articles for article (PubMed ID: 20408766)
1. αII-spectrin breakdown products (SBDPs): diagnosis and outcome in severe traumatic brain injury patients.
Mondello S; Robicsek SA; Gabrielli A; Brophy GM; Papa L; Tepas J; Robertson C; Buki A; Scharf D; Jixiang M; Akinyi L; Muller U; Wang KK; Hayes RL
J Neurotrauma; 2010 Jul; 27(7):1203-13. PubMed ID: 20408766
[TBL] [Abstract][Full Text] [Related]
2. Clinical significance of alphaII-spectrin breakdown products in cerebrospinal fluid after severe traumatic brain injury.
Pineda JA; Lewis SB; Valadka AB; Papa L; Hannay HJ; Heaton SC; Demery JA; Liu MC; Aikman JM; Akle V; Brophy GM; Tepas JJ; Wang KK; Robertson CS; Hayes RL
J Neurotrauma; 2007 Feb; 24(2):354-66. PubMed ID: 17375999
[TBL] [Abstract][Full Text] [Related]
3. alphaII-Spectrin breakdown product cerebrospinal fluid exposure metrics suggest differences in cellular injury mechanisms after severe traumatic brain injury.
Brophy GM; Pineda JA; Papa L; Lewis SB; Valadka AB; Hannay HJ; Heaton SC; Demery JA; Liu MC; Tepas JJ; Gabrielli A; Robicsek S; Wang KK; Robertson CS; Hayes RL
J Neurotrauma; 2009 Apr; 26(4):471-9. PubMed ID: 19206997
[TBL] [Abstract][Full Text] [Related]
4. Detection of alphaII-spectrin and breakdown products in humans after severe traumatic brain injury.
Cardali S; Maugeri R
J Neurosurg Sci; 2006 Jun; 50(2):25-31. PubMed ID: 16841024
[TBL] [Abstract][Full Text] [Related]
5. Spectrin breakdown products in the cerebrospinal fluid in severe head injury--preliminary observations.
Farkas O; Polgár B; Szekeres-Barthó J; Dóczi T; Povlishock JT; Büki A
Acta Neurochir (Wien); 2005 Aug; 147(8):855-61. PubMed ID: 15924207
[TBL] [Abstract][Full Text] [Related]
6. Accumulation of non-erythroid alpha II-spectrin and calpain-cleaved alpha II-spectrin breakdown products in cerebrospinal fluid after traumatic brain injury in rats.
Pike BR; Flint J; Dutta S; Johnson E; Wang KK; Hayes RL
J Neurochem; 2001 Sep; 78(6):1297-306. PubMed ID: 11579138
[TBL] [Abstract][Full Text] [Related]
7. The role of spectrin breakdown products in patients with traumatic brain injury: a systematic review and meta-analysis.
Liu Y; Yao X; Lv X; Qian J
Neurol Sci; 2023 Apr; 44(4):1171-1183. PubMed ID: 36547778
[TBL] [Abstract][Full Text] [Related]
8. Alpha II-spectrin breakdown products serve as novel markers of brain injury severity in a canine model of hypothermic circulatory arrest.
Weiss ES; Wang KK; Allen JG; Blue ME; Nwakanma LU; Liu MC; Lange MS; Berrong J; Wilson MA; Gott VL; Troncoso JC; Hayes RL; Johnston MV; Baumgartner WA
Ann Thorac Surg; 2009 Aug; 88(2):543-50. PubMed ID: 19632410
[TBL] [Abstract][Full Text] [Related]
9. Role of α-II-spectrin breakdown products in the prediction of the severity and clinical outcome of acute traumatic brain injury.
Chen S; Shi Q; Zheng S; Luo L; Yuan S; Wang X; Cheng Z; Zhang W
Exp Ther Med; 2016 May; 11(5):2049-2053. PubMed ID: 27168849
[TBL] [Abstract][Full Text] [Related]
10. Accumulation of calpain and caspase-3 proteolytic fragments of brain-derived alphaII-spectrin in cerebral spinal fluid after middle cerebral artery occlusion in rats.
Pike BR; Flint J; Dave JR; Lu XC; Wang KK; Tortella FC; Hayes RL
J Cereb Blood Flow Metab; 2004 Jan; 24(1):98-106. PubMed ID: 14688621
[TBL] [Abstract][Full Text] [Related]
11. A novel marker for traumatic brain injury: CSF alphaII-spectrin breakdown product levels.
Ringger NC; O'Steen BE; Brabham JG; Silver X; Pineda J; Wang KK; Hayes RL; Papa L
J Neurotrauma; 2004 Oct; 21(10):1443-56. PubMed ID: 15672634
[TBL] [Abstract][Full Text] [Related]
12. Biomarkers improve clinical outcome predictors of mortality following non-penetrating severe traumatic brain injury.
Papa L; Robertson CS; Wang KK; Brophy GM; Hannay HJ; Heaton S; Schmalfuss I; Gabrielli A; Hayes RL; Robicsek SA
Neurocrit Care; 2015 Feb; 22(1):52-64. PubMed ID: 25052159
[TBL] [Abstract][Full Text] [Related]
13. Ubiquitin C-terminal hydrolase is a novel biomarker in humans for severe traumatic brain injury.
Papa L; Akinyi L; Liu MC; Pineda JA; Tepas JJ; Oli MW; Zheng W; Robinson G; Robicsek SA; Gabrielli A; Heaton SC; Hannay HJ; Demery JA; Brophy GM; Layon J; Robertson CS; Hayes RL; Wang KK
Crit Care Med; 2010 Jan; 38(1):138-44. PubMed ID: 19726976
[TBL] [Abstract][Full Text] [Related]
14. Temporal response profiles of serum ubiquitin C-terminal hydrolase-L1 and the 145-kDa alpha II-spectrin breakdown product after severe traumatic brain injury in children.
Metzger RR; Sheng X; Niedzwecki CM; Bennett KS; Morita DC; Zielinski B; Schober ME
J Neurosurg Pediatr; 2018 Oct; 22(4):369-374. PubMed ID: 29957142
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of alpha-II-spectrin breakdown products as potential biomarkers for early recognition and severity of aneurysmal subarachnoid hemorrhage.
Papa L; Rosenthal K; Silvestri F; Axley JC; Kelly JM; Lewis SB
Sci Rep; 2018 Sep; 8(1):13308. PubMed ID: 30190542
[TBL] [Abstract][Full Text] [Related]
16. Serum concentrations of ubiquitin C-terminal hydrolase-L1 and αII-spectrin breakdown product 145 kDa correlate with outcome after pediatric TBI.
Berger RP; Hayes RL; Richichi R; Beers SR; Wang KK
J Neurotrauma; 2012 Jan; 29(1):162-7. PubMed ID: 22022780
[TBL] [Abstract][Full Text] [Related]
17. Alpha-II spectrin breakdown products in aneurysmal subarachnoid hemorrhage: a novel biomarker of proteolytic injury.
Lewis SB; Velat GJ; Miralia L; Papa L; Aikman JM; Wolper RA; Firment CS; Liu MC; Pineda JA; Wang KK; Hayes RL
J Neurosurg; 2007 Oct; 107(4):792-6. PubMed ID: 17937225
[TBL] [Abstract][Full Text] [Related]
18. Clinical utility of serum levels of ubiquitin C-terminal hydrolase as a biomarker for severe traumatic brain injury.
Mondello S; Linnet A; Buki A; Robicsek S; Gabrielli A; Tepas J; Papa L; Brophy GM; Tortella F; Hayes RL; Wang KK
Neurosurgery; 2012 Mar; 70(3):666-75. PubMed ID: 21937927
[TBL] [Abstract][Full Text] [Related]
19. Quantitative studies of caspase-3 catalyzed αII-spectrin breakdown.
Witek MA; Fung LW
Brain Res; 2013 Oct; 1533():1-15. PubMed ID: 23948103
[TBL] [Abstract][Full Text] [Related]
20. Brain injury biomarkers may improve the predictive power of the IMPACT outcome calculator.
Czeiter E; Mondello S; Kovacs N; Sandor J; Gabrielli A; Schmid K; Tortella F; Wang KK; Hayes RL; Barzo P; Ezer E; Doczi T; Buki A
J Neurotrauma; 2012 Jun; 29(9):1770-8. PubMed ID: 22435839
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
